Once you reach your maintenance dose (usually after 48 weeks), weekly loss often accelerates to 12 pounds as appetite suppression becomes consistent and pronounced
Wegovy has not yet been registered in South Africa
About this article Cite this article Ren, S., Zhou, F., Xu, C
TALTZ 80 mg Q4W inhibited the progression of structural joint damage (mTSS) compared to placebo at Week 16
Tirzepatide is known as a dual GIP and GLP-1 receptor agonist
Equitable access may include considering the use of a community-based multidisciplinary team approach, to include social prescribing, community dietetics and other appropriate services, where available